338 related articles for article (PubMed ID: 29197748)
1. Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine.
Kwon H; Kim M; Seo Y; Moon YS; Lee HJ; Lee K; Lee H
Biomaterials; 2018 Feb; 156():172-193. PubMed ID: 29197748
[TBL] [Abstract][Full Text] [Related]
2. Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications.
Patel S; Athirasala A; Menezes PP; Ashwanikumar N; Zou T; Sahay G; Bertassoni LE
Tissue Eng Part A; 2019 Jan; 25(1-2):91-112. PubMed ID: 29661055
[TBL] [Abstract][Full Text] [Related]
3. Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges.
Steinle H; Behring A; Schlensak C; Wendel HP; Avci-Adali M
Stem Cells; 2017 Jan; 35(1):68-79. PubMed ID: 27250673
[TBL] [Abstract][Full Text] [Related]
4. Immuno-engineered mRNA combined with cell adhesive niche for synergistic modulation of the MSC secretome.
Drzeniek NM; Kahwaji N; Schlickeiser S; Reinke P; Geißler S; Volk HD; Gossen M
Biomaterials; 2023 Mar; 294():121971. PubMed ID: 36634491
[TBL] [Abstract][Full Text] [Related]
5. mRNA vaccines: the most recent clinical applications of synthetic mRNA.
Kwon S; Kwon M; Im S; Lee K; Lee H
Arch Pharm Res; 2022 Apr; 45(4):245-262. PubMed ID: 35426547
[TBL] [Abstract][Full Text] [Related]
6. Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration.
Johler SM; Rejman J; Guan S; Rosenecker J
PLoS One; 2015; 10(9):e0137504. PubMed ID: 26352268
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.
Guan S; Rosenecker J
Gene Ther; 2017 Mar; 24(3):133-143. PubMed ID: 28094775
[TBL] [Abstract][Full Text] [Related]
8. mRNA-based therapies: Preclinical and clinical applications.
Qureischi M; Mohr J; Arellano-Viera E; Knudsen SE; Vohidov F; Garitano-Trojaola A
Int Rev Cell Mol Biol; 2022; 372():1-54. PubMed ID: 36064262
[TBL] [Abstract][Full Text] [Related]
9. mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration.
Chanda PK; Sukhovershin R; Cooke JP
Cells; 2021 Jan; 10(1):. PubMed ID: 33477787
[TBL] [Abstract][Full Text] [Related]
10. Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy.
Youn H; Chung JK
Expert Opin Biol Ther; 2015; 15(9):1337-48. PubMed ID: 26125492
[TBL] [Abstract][Full Text] [Related]
11. Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics.
Kang DD; Li H; Dong Y
Adv Drug Deliv Rev; 2023 Aug; 199():114961. PubMed ID: 37321375
[TBL] [Abstract][Full Text] [Related]
12. Cell engineering with synthetic messenger RNA.
Rabinovich PM; Weissman SM
Methods Mol Biol; 2013; 969():3-28. PubMed ID: 23296924
[TBL] [Abstract][Full Text] [Related]
13. mRNA - A game changer in regenerative medicine, cell-based therapy and reprogramming strategies.
Chabanovska O; Galow AM; David R; Lemcke H
Adv Drug Deliv Rev; 2021 Dec; 179():114002. PubMed ID: 34653534
[TBL] [Abstract][Full Text] [Related]
14. The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics.
Muslimov A; Tereshchenko V; Shevyrev D; Rogova A; Lepik K; Reshetnikov V; Ivanov R
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834268
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules.
Zhang J; Liu Y; Li C; Xiao Q; Zhang D; Chen Y; Rosenecker J; Ding X; Guan S
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765153
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives.
Gómez-Aguado I; Rodríguez-Castejón J; Vicente-Pascual M; Rodríguez-Gascón A; Solinís MÁ; Del Pozo-Rodríguez A
Nanomaterials (Basel); 2020 Feb; 10(2):. PubMed ID: 32093140
[TBL] [Abstract][Full Text] [Related]
17. mRNA-based therapeutics--developing a new class of drugs.
Sahin U; Karikó K; Türeci Ö
Nat Rev Drug Discov; 2014 Oct; 13(10):759-80. PubMed ID: 25233993
[TBL] [Abstract][Full Text] [Related]
18. Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.
Martínez J; Lampaya V; Larraga A; Magallón H; Casabona D
Front Mol Biosci; 2023; 10():1248511. PubMed ID: 37842641
[TBL] [Abstract][Full Text] [Related]
19. Introduction to regenerative medicine and tissue engineering.
Stoltz JF; Decot V; Huseltein C; He X; Zhang L; Magdalou J; Li YP; Menu P; Li N; Wang YY; de Isla N; Bensoussan D
Biomed Mater Eng; 2012; 22(1-3):3-16. PubMed ID: 22766697
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Synthesis of Modified RNA for Cardiac Gene Therapy.
Sultana N; Sharkar MTK; Hadas Y; Chepurko E; Zangi L
Methods Mol Biol; 2021; 2158():281-294. PubMed ID: 32857381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
